• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Behind Every Successful eCOA Solution is a Robust Scientific Strategy
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Kyongbo Pharmaceutical

    Societal CDMO

    Baxter BioPharma Solutions

    Biosynth Carbosynth

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Kyongbo Pharmaceutical

    Societal CDMO

    Baxter BioPharma Solutions

    Biosynth Carbosynth

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Effective Project Management

    Creating opportunities for lower costs and faster time-to-market

    Related CONTENT
    • Planning For Better Clinical Trials
    • Choosing and Managing a CDMO
    • Roberto Almodóvar Febles Joins Pii as Head of Aseptic Operations
    • Pii Names Head of Aseptic Operations
    • Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines
    Peter Soelkner09.03.09

    Effective Project Management



    Creating opportunities for lower costs and faster time-to-market



    By Peter Soelkner



    The squeeze is on. The cost of development, discovery and manufacturing of new drugs is continuously rising. Economic realities are forcing pharmaceutical and biotechnology companies to be on the lookout for an enduring solution to meet market challenges and control development and manufacturing costs.

    Moreover, to control costs, streamline the development cycle and maximize their return on investment, many pharmaceutical companies are embracing collaboration with CMOs. While these productive partnerships offer significant value-added benefits, they also open a new set of challenges.

    A drug’s time-to-market can take years, and there is no guarantee it will succeed, no matter how much research, effort and financial resources are ultimately invested in a product. In addition, pharmaceutical and biotech companies continue to face increasing market challenges, including stringent regulatory standards, strict quality control criteria and stronger global competition. These issues can make effective communication increasingly difficult between the stakeholders of the pharmaceutical company and their collaborative CMO. Can all of these challenges be addressed — and solved — to make contract manufacturing a worthwhile pursuit?

    Through effective project management and industry experience, the answer is “yes.” Project management for drug development is a highly specialized and relatively new practice. But with the right project management process in place, companies can drastically reduce a product’s time-to-market, cut their costs and increase their RoI. First, however, they must select a CMO that can prove its project management prowess.

    A Healthy Start



    Regardless of the industry, project management typically addresses several universal steps: initiation, planning and coordination, controlling, and closing. In the pharmaceutical industry, these steps are increasingly more complicated, and the risks involved with drug research, discovery and development must be taken into account from the very beginning.

    To ensure a successful partnership, pharmaceutical and biotechnology companies must engage a CMO that can fulfill their needs to provide a streamlined turn-key approach that reduces a drug’s time-to-market. Eager to win business in today’s competitive environment, some CMOs will submit unreasonably low project estimates. This practice often leads to the CMO cutting corners to control costs, putting the entire project at risk.

    Mitigating these risks requires a thorough upfront analysis of the entire project. From formulation to packaging and more, specifications of each aspect of the project — as well as the product’s specific attributes — must be discussed. Therefore, it is very helpful to start a relationship with the CMO in the early development phase (preclinical / Phase I).

    It’s also beneficial to consider a CMO that abides by the standards set forth by a valued industry resource, such as the International Project Management Association (IPMA), a non-profit organization that represents 45 national project management associations on the international level.

    In addition to establishing testing processes that ensure project managers are prepared for the tasks that lie ahead, IPMA facilitates best practice models that are used in quality project management procedures. These include management processes, methods, techniques, tools and functions that help boost efficiency by keeping a project on schedule and within budget.

    The Right Team



    Once a CMO with the experience and capacity to successfully complete the project has been selected, the real work begins. To ensure an effectively managed project, a project manager must be designated by each partner organization. The project manager should:
    • Demonstrate a background in natural sciences;
    • Show professional experience working with and managing teams that include scientists and manufacturing specialists;
    • Offer significant soft skills, such as leadership, negotiation skills and public speaking

    Once project managers have been chosen, the selection of members for each organization’s project team is critical. The CMO must be prepared to address and solve all existing and potential issues throughout the entire development and production process. To ensure a streamlined process, the CMO’s team should include members with expertise in:
    • Packaging
    • Development
    • Process development
    • Qualification and validation
    • Production
    • Regulatory affairs
    • Quality management
    • Supply chain management

    To maintain continuity and ensure effective communication, the pharmaceutical company’s project management team should mirror the CMO’s team. A steering committee, comprised of senior managers from both companies, should be developed to serve as an interface between the two companies, keep the teams abreast of the project’s progress and make critical decisions regarding investments, timelines and other key issues.

    Creating the Plan



    Investing resources in careful and detailed planning in the earliest phases of a project results in rapid project implementation and the ability to properly plan for potential issues throughout the initial product launch, if not throughout the entire lifecycle of the drug.

    Proper planning includes providing each team member, from both the pharmaceutical company and the CMO, the opportunity to submit questions to the group based on each member’s own functional expertise. The use of a standardized questionnaire is an effective tool that can act as a guide throughout all project phases. Consider an example of a drug that is delivered via a pre-filled syringe. The questionnaire might ask:
    • Is the active substance incompatible with any materials commonly used in packaging?
    • How much silicon is required for the plunger to move smoothly?
    • Is the substance sensitive to oxygen?

    A well-versed CMO will have the knowledge and experience to ask more detailed questions to uncover pitfalls early on in the process. By thoroughly investigating each and every question, serious delays and problems can be avoided in the later stages of the project. Potential changes should also be taken into account in case the process itself creates new and unforeseen situations.

    Following review of the questionnaire, the CMO should outline the plan step-by-step to:
    • Clearly define project goals
    • Create well-defined workpackages and responsibilities
    • Identify critical activities and milestones
    • Design and analyze production processes and procedures and develop a complete risk analysis
    • Share all data and project information with members of both teams
    • Remain flexible and willing to adjust the process if the situation warrants

    Partnering with an experienced CMO that understands where potential problems lie will expedite the planning process and reduce the drug’s overall time-to-market.

    Embracing ERP



    Successful project management includes the utilization of effective technology systems. In most cases, Enterprise Re-source Planning (ERP) software offers solutions to:
    • Collate information from existing catalogues
    • Calculate and describe resources critical to the project
    • Track costs
    • Divide the project into individual phases for easy tracking (project gates)

    To maintain time and budget goals, the CMO’s project manager should review ERP reports monthly at a minimum. In addition to staying on course, this will allow the project to be adjusted to current situations if needed.

    Opening the Channels of Communication



    Effective communication and sharing of information is a key element and should flow freely between all stakeholders throughout every phase of the project. Such dialogue prevents failures due to misunderstandings, lack of information, erroneous interpretation and overlooked risks, and creates a positive project relationship between the two partners and all team members.

    To ensure each party is fully aware of a project’s progress and informed of any potential roadblocks, the project managers from both organizations should schedule and facilitate weekly conference calls and/or project management meetings to track accomplishments and missteps, as well as to determine any required solutions. This will ensure the project is being handled properly and communication channels are open.

    The project managers should also document and distribute regularly scheduled reports on centralized platforms, such as Internet share points, to ensure all teams are abreast of the latest project information. Internal and external access, combined with conclusive and traceable documentation through the process development and implementation phases, are essential for maintaining a seamless communication flow.

    In addition to open communication channels, each project requires a well-thought-out communication tree. What if a decision needs to be made urgently, yet is beyond the project manager’s scope? The entire steering committee should be assembled to address the issue. If a resolution is needed even faster, each organization’s regular hierarchy must be approached.

    From Planning to Realization



    Once the playbook has been written and the experts have molded into a strong project team, work can begin. During the development and validation phases, work packages outlined in the plan are transformed into a tangible product. The project manager continues to play a critical role in this phase, closely monitoring project needs and overall costs to avoid delays, manage crises and ensure the project remains on track based on tactics developed during the planning phase.

    To avoid unnecessary delays or expenses, the project management team must carefully plan and constantly track the project’s progress. Knowledge transfer and open communication are crucial during this particular phase in the process. To assure this, well-defined milestones and project gates at the end of critical or important project phases have to be established to control and review the project progress against the plan for:
    • Quality of achieved objectives / work packages
    • Needed resources / cost
    • Time to market

    Crisis management is especially important during this final phase as a crisis can have serious impact on an organization’s reputation and can drastically affect customer confidence. Pharmaceu-tical companies are already faced with increasing production costs, intensifying global competition and growing regulatory stringency. Each project will have its own issues and challenges. Establishing a strong crisis management plan allows the project manager to control many situations and minimize or even avoid possible negative impact that results from unfavorable situations.

    At the end of a project the team will conduct a thorough project review and develop lessons learned that may help improve future projects.

    A Successful Conclusion



    Pharmaceutical project management is a complex issue, but successful outcomes are consistently possible with the right elements in place. Key components include:
    • A strong management commitment from the very beginning;
    • An understanding of product-specific needs, process know-how and proven project management skills;
    • A well-structured approach in all project phases;
    • Project tools for Planning and Controlling;
    • Conclusive and traceable documentation through process development and implementation;
    • Identification and quick follow-up on critical project tasks

    A careful and detailed approach can make a significant difference in the outcome of a drug’s success by saving time and money while improving results. Each project must be managed within its own set of circumstances. And a CMO that understands its uniqueness can make all the difference in the world.

    Peter Soelkner is managing director of Vetter Pharma International GmbH.
    Related Searches
    • Pharma
    • Manufacturing
    • formulation
    • Development
    Suggested For You
    Planning For Better Clinical Trials Planning For Better Clinical Trials
    Choosing and Managing a CDMO Choosing and Managing a CDMO
    Roberto Almodóvar Febles Joins Pii as Head of Aseptic Operations Roberto Almodóvar Febles Joins Pii as Head of Aseptic Operations
    Pii Names Head of Aseptic Operations Pii Names Head of Aseptic Operations
    Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines
    Altasciences Appoints Dr. Bruce Frank as VP, CDMO Operations Altasciences Appoints Dr. Bruce Frank as VP, CDMO Operations
    CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers
    CRO Charnwood Molecular Expands Capabilities CRO Charnwood Molecular Expands Capabilities
    Can mRNA Facilities Really be Flexible?  Can mRNA Facilities Really be Flexible?
    Clinical to Commercial Manufacturing: Selecting the Right CDMO for Your Sterile Drug Product Clinical to Commercial Manufacturing: Selecting the Right CDMO for Your Sterile Drug Product
    From Capital Builds to Staff Augmentation: Tips to Achieving Integrated CQV Strategies From Capital Builds to Staff Augmentation: Tips to Achieving Integrated CQV Strategies
    Biovectra Inc. Unveils New Logo and Brand Biovectra Inc. Unveils New Logo and Brand
    LabConnect, Cryoport Partner to Support Triumvira Trial Logistics LabConnect, Cryoport Partner to Support Triumvira Trial Logistics
    Small Molecule Drug Development Trends Small Molecule Drug Development Trends
    Vetter Development Service Vetter Development Service

    Related Columns

    • Planning For Better Clinical Trials

      Planning For Better Clinical Trials

      Faster, smoother and more approvable clinical trials start with you.
      Ben Locwin, Contributing Editor 09.09.21

    • Choosing and Managing a CDMO

      Choosing and Managing a CDMO

      Speed up your time-to-market, keep development costs under control and smooth the FDA approval and commercial launch process.
      Dana Toops, President, Avema Pharma Solutions 09.09.21

    • Aseptic Processing | Breaking News | Industry News | Promotions & Moves
      Roberto Almodóvar Febles Joins Pii as Head of Aseptic Operations

      Roberto Almodóvar Febles Joins Pii as Head of Aseptic Operations

      Will oversee and manage day-to-day aseptic manufacturing.
      09.03.21


    • Aseptic Processing | Breaking News | cGMP Manufacture | Promotions & Moves
      Pii Names Head of Aseptic Operations

      Pii Names Head of Aseptic Operations

      Roberto Almodóvar Febles will oversee and manage day-to-day aseptic manufacturing.
      08.31.21

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines

      Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines

      The annual production is expected to exceed 100 million finished doses annually for Latin America.
      08.26.21

    Loading, Please Wait..
    Trending
    • Almac Invests $65M To Expand North American HQ
    • Just – Evotec Biologics And Alpine Immune Sciences Expand Partnership
    • West Pharmaceutical Makes Strategic Investment In Latch Medical
    • AskBio Appoints Clinical Ops Executives
    • Catalent To Acquire Metrics Contract Services For $475M
    Breaking News
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    • Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership
    • Almac Invests $65M to Expand North American HQ
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Consumers are Clamoring for Vintage Glam: Spate
    Kayali’s Lovefest Fragrance, Newell’s New Candle and HydraFacial’s Record Financial Results
    Self Care Trumps Home Care Post-Covid
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login